Rate Us
Milwaukee Eye Care Associates - Facebook Milwaukee Eye Care Associates - Twitter Milwaukee Eye Care Associates - Instagram Milwaukee Eye Care Associates - YouTube Milwaukee Eye Care Associates - Blog

BaysideBrookfieldFranklinMilwaukee 414.271.2020

3D Eye Online

iStent Treatment for Glaucoma

What is the iStent?

Milwaukee Eye Care Associates is pleased to offer the latest advancements in glaucoma treatment technology.  The iStent® Trabecular Micro-Bypass Stent is a treatment option to reduce eye pressure for patients with both cataracts and glaucoma.

The iStent is FDA-approved for use in conjunction with cataract surgery to reduce eye pressure in adult patients with mild-to-moderate open-angle glaucoma currently being treated with glaucoma medicine.

iStent works similarly to the stents used to prevent heart attacks and strokes. When blood vessels get clogged, a stent creates access to the vessel flow.

How Does the iStent work?

For those suffering from glaucoma, the eye’s natural drainage pathway becomes less effective over time. The iStent creates a permanent pathway to bypass the ineffective drain and improve the eye’s natural outflow. Restoring this mechanism lowers and controls pressure within the eye.

The iStent is implanted during your cataract surgery procedure. Once implanted, the iStent will begin working to safely and effectively manage intraocular pressure. Patients who receive iStent may also be able to reduce usage of glaucoma medications, but this will be at the discretion of your Milwaukee Eye Care Associates physician.

iStent Milwaukee Eye Care Associates

View Video

iStent: The world’s smallest medical implant delivers big results in mild-to-moderate open-angle glaucoma.

While mild-to-moderate open-angle glaucoma is very common, many people are unaware of their condition, especially in the early stages, when their vision may be unaffected. In many people, open-angle glaucoma is characterized by an increase in the intraocular pressure (IOP) of your eye. This pressure is caused by the buildup of fluid within the eye. Too much fluid raises pressure, which can cause the gradual loss of vision. And while glaucoma moves slowly, its damage is irreparable.

The world’s tiniest medical device—iStent—is 20,000 times smaller than the intraocular lenses (IOL) used in your cataract surgery. But the size of iStent is only part of its story. By increasing the eye’s ability to drain fluid, this technology is designed to reduce the pressure in your eye.

In a U.S. clinical study, 68% of glaucoma patients who received iStent remained medication free at 12 months while sustaining a target IOP of = 21 mm Hg vs. only 50% of patients who underwent cataract surgery alone.

To schedule an appointment for a glaucoma evaluation with Dr. Nicholas Frame, please call Milwaukee Eye Care Associates, S.C. at 414-271-2020.

+ -